跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,196 条关于
“Dermavon Holdings Limited”
全部
12,196
临床试验
1,217
药物
106
机构
1,466
资讯
9,407
去年
China Medical System's MG-K10 Advances to Phase III Trials for Chronic Spontaneous Urticaria Treatment
9个月前
China Medical System's JAK1 Inhibitor Povorcitinib Receives Breakthrough Therapy Designation for Vitiligo Treatment
15天前
Lumirix® (Ruxolitinib Phosphate Cream) Approved in China for Mild-to-Moderate Atopic Dermatitis
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
European Commission Approves Novo Holdings' $16.5B Catalent Acquisition
2年前
Transcenta Announces Positive Interim Results, Highlights Osemitamab and Blosozumab Progress
2年前
Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers
去年
HBM Holdings Secures NMPA Approval to Begin COPD Drug Trials in China
2年前
Immunocore and Bristol Myers Squibb Collaborate on Phase 3 Trial for Advanced Cutaneous Melanoma
去年
ALX Oncology's Evorpacept Shows Promise in Multiple Cancer Trials
第 1 页,共 941 页
上一页
下一页